Axena Health, Mayo Clinic Augment Their Collaboration

Axena Health Inc. is expanding its partnership with Mayo Clinic to include the development of new offerings for women with pelvic floor disorders. The expanded collaboration builds on the two entities’ pairing announced last February.

The expanded union will leverage Mayo Clinic’s clinical expertise to develop a new solution separate from Axena Health’s flagship Leva Pelvic Health System. The new product will be developed and owned by Axena Health and will integrate advanced artificial intelligence to analyze data and deliver more personalized care pathways for women with pelvic health conditions.

The collaboration seeks to address a critical gap in women’s pelvic healthcare: Too often, women with pelvic floor disorders fall off the care pathway before completing treatment. Axena Health’s goal is to help keep patients engaged throughout their treatment journey while enabling clinicians to deliver more tailored interventions including, where appropriate, second- and third-line treatments, based on individual symptom profiles, treatment responses, and adherence patterns.

“As a urogynecologist, I see how women with pelvic floor disorders fall off the care pathway before completing treatment—not because they don’t want help, but because the system isn’t built to meet them where they are,” Axena Health Interim CEO/Chief Medical Officer Dr. Samantha Pulliam, M.D., said. “This collaboration with Mayo Clinic allows us to work toward tackling that gap head-on by combining Mayo Clinic’s clinical expertise with AI-driven personalization to help clinicians keep patients engaged and deliver more personalized, effective care throughout their treatment journey.”

The new product development program is slated to focus initially on urinary incontinence and overactive bladder (OAB), with the platform designed to serve as a framework for additional pelvic floor treatment pathways. Specific product details and timelines remain in early development stages.

“This expanded collaboration is aligned with Axena Health’s commitment to advancing innovative, evidence-based care for women,” Axena Health Board Executive Chair Shacey Petrovic stated. “We’re striving to build a future where women have access to the personalized care they deserve, and where clinicians have the tools to make that happen.”

Axena Health Inc. is a women’s health company striving to redefine the standard of care for pelvic health conditions through clinically proven, non-invasive treatments. Its physician-prescribed Leva Pelvic Health System empowers women with effective, supervised pelvic floor muscle training at home, combining cutting-edge motion-based technology with evidence-based treatment and personalized coaching. The company envisions a future where pelvic health is prioritized, destigmatized, and effectively treated.

The Leva Pelvic Health System is intended to (1) strengthen pelvic floor muscles, (2) rehabilitate and train weak pelvic floor muscles for treating stress, mixed, and mild to moderate urgency urinary incontinence (including overactive bladder) in women and (3) rehabilitate and train weak pelvic floor muscles for the first-line treatment of chronic fecal incontinence (>3-month uncontrolled passage of feces) in women.